Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings

Aims: Catatonia is a neuropsychiatric syndrome characterized by a paucity of movement and speech. Benzodiazepines are the mainstay of treatment for catatonia, but a subset of patients do not respond. While electroconvulsive therapy is another treatment option for catatonia, access can be limited. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Holly Hodge, Shaikh Ullahansari, Blake Berry
Format: Article
Language:English
Published: Cambridge University Press 2025-06-01
Series:BJPsych Open
Online Access:https://www.cambridge.org/core/product/identifier/S2056472425107308/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849417150919344128
author Holly Hodge
Shaikh Ullahansari
Blake Berry
author_facet Holly Hodge
Shaikh Ullahansari
Blake Berry
author_sort Holly Hodge
collection DOAJ
description Aims: Catatonia is a neuropsychiatric syndrome characterized by a paucity of movement and speech. Benzodiazepines are the mainstay of treatment for catatonia, but a subset of patients do not respond. While electroconvulsive therapy is another treatment option for catatonia, access can be limited. This case report discusses the use of zolpidem, a hypnotic non-benzodiazepine GABA-A receptor modulator, in a patient with benzodiazepine-resistant catatonia.
format Article
id doaj-art-f1bd287d74ca4c5ab02db0529df7516e
institution Kabale University
issn 2056-4724
language English
publishDate 2025-06-01
publisher Cambridge University Press
record_format Article
series BJPsych Open
spelling doaj-art-f1bd287d74ca4c5ab02db0529df7516e2025-08-20T03:32:55ZengCambridge University PressBJPsych Open2056-47242025-06-0111S303S30310.1192/bjo.2025.10730Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited SettingsHolly Hodge0Shaikh Ullahansari1Blake Berry2Texas A&M College of Medicine, Dallas, USATexas A&M College of Medicine, Dallas, USAJohn Peter Smith Hospital, Fort Worth, USAAims: Catatonia is a neuropsychiatric syndrome characterized by a paucity of movement and speech. Benzodiazepines are the mainstay of treatment for catatonia, but a subset of patients do not respond. While electroconvulsive therapy is another treatment option for catatonia, access can be limited. This case report discusses the use of zolpidem, a hypnotic non-benzodiazepine GABA-A receptor modulator, in a patient with benzodiazepine-resistant catatonia.https://www.cambridge.org/core/product/identifier/S2056472425107308/type/journal_article
spellingShingle Holly Hodge
Shaikh Ullahansari
Blake Berry
Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
BJPsych Open
title Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
title_full Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
title_fullStr Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
title_full_unstemmed Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
title_short Zolpidem for Catatonia Refractory to Benzodiazepines in Resource-Limited Settings
title_sort zolpidem for catatonia refractory to benzodiazepines in resource limited settings
url https://www.cambridge.org/core/product/identifier/S2056472425107308/type/journal_article
work_keys_str_mv AT hollyhodge zolpidemforcatatoniarefractorytobenzodiazepinesinresourcelimitedsettings
AT shaikhullahansari zolpidemforcatatoniarefractorytobenzodiazepinesinresourcelimitedsettings
AT blakeberry zolpidemforcatatoniarefractorytobenzodiazepinesinresourcelimitedsettings